Orion Oyj BEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 80.95 EUR | 82,25 EUR | 55,741 EUR |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - EUR | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 109.492.933 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Orion Oyj B
Mitarbeiter 4.000
Handelsplatz HE
Ticker Symbol ORNBV
IPO Datum -
Adresse Orionintie 1A, Espo, Finland, 02200
Webseite https://www.orionpharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Liisa Hurme Ph.D. | President, CEO & Chairman of Executive Management Board |
| 2 | Mr. Rene Lindell M.Sc., Ph.D. | CFO & Member of Group Executive Management Board |
| 3 | Ms. Satu Ahomäki M.Sc., M.Sc. (Econ.) | Executive VP of Generics and Consumer Health & Member of the Exe. Mgmt. Board |
| 4 | Prof. Outi Vaarala M.D., Ph.D. | Executive VP of Research & Development and Member of the Exe. Mgmt. Board |
| 5 | Mr. Juhani Kankaanpaa M.Sc. | Executive VP of Global Operations & Member of Executive Management Board |
| 6 | Mr. Niclas Lindstedt EMBA, M.Sc. | Executive VP of Animal Health & Member of the Exe. Mgmt. Board |
| 7 | Mr. Hao Pan M.Sc. | Executive VP of the Branded Products & Member of the Exe. Mgmt. Board |
| 8 | Ms. Julia Irene Macharey | Executive VP of People & Culture & Member of Management Board |
| 9 | Mr. Mikko Kemppainen | General Counsel, Secretary to the Board & Member of Executive Management Board |
| 10 | Mr. Berkeley Vincent | Executive Vice President of Innovative Medicines & Member of Management Board |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.